SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001171843-12-001415
Filing Date
2012-04-25
Accepted
2012-04-25 09:01:09
Documents
7
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 40-F/A f40fa_042512.htm 40-F/A 31197
  Complete submission text file 0001171843-12-001415.txt   2765456

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT crme-20111231.xml EX-101.INS 643431
3 XBRL TAXONOMY EXTENSION SCHEMA crme-20111231.xsd EX-101.SCH 21853
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crme-20111231_cal.xml EX-101.CAL 21672
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crme-20111231_def.xml EX-101.DEF 104505
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crme-20111231_lab.xml EX-101.LAB 109039
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crme-20111231_pre.xml EX-101.PRE 105408
Mailing Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3
Business Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 40-F/A | Act: 34 | File No.: 000-29338 | Film No.: 12778125
SIC: 2834 Pharmaceutical Preparations